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ABSTRACT
Osteoblasts (OBs) exert a prominent regulatory effect on hematopoietic stem cells (HSCs). We evaluated the difference in hematopoietic
expansion and function in response to co-culture with OBs at various stages of development. Murine calvarial OBs were seeded directly
(fresh) or cultured for 1, 2, or 3 weeks prior to seeding with 1000 Lin-Sca1þcKitþ (LSK) cells for 1 week. Significant increases in the
following hematopoietic parameters were detected when comparing co-cultures of fresh OBs to co-cultures containing OBs cultured for
1,2,or3weeks: totalhematopoieticcell number(uptoa3.4-foldincrease), totalcolony formingunit (CFU)numberinLSKprogeny(up to
an 18.1-fold increase), and percentage of Lin-Sca1þ cells (up to a 31.8-fold increase). Importantly, these studies were corroborated by in
vivo reconstitution studies in which LSK cells maintained in fresh OB co-cultures supported a significantly higher level of chimerism than
cells maintained in co-cultures containing 3-week OBs. Characterization of OBs cultured for 1, 2, or 3 weeks with real-time PCR and
functionalmineralization assays showedthat OB maturation increasedwith culture duration but wasnot affected by the presence ofLSK
cells in culture. Linear regression analyses of multiple parameters measured in these studies show that fresh, most likely more immature
OBs better promote hematopoietic expansion and function than cultured, presumably more mature OBs and suggest that the
hematopoiesis-enhancing activity is mediated by cells present in fresh OB cultures de novo.  2011 American Society for Bone and
Mineral Research.
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Introduction
R
ecent work has expanded our understanding of the
hematopoietic microenvironment in bone and the role of
osteoblasts (OBs) in the regulation of hematopoietic stem cell
(HSC) survival and differentiation. A hypothesis for a specialized
microenvironment, or ‘‘niche,’’ for HSC differentiation was first
posited by Schofield in 1978.
(1) Shortly thereafter, a connection
between bone and blood dyscrasias was suggested.
(2) Although
several anatomical locations of hematopoietic activity outside
longbones have been ascertained
(3–8) and a perisinusoidal niche
for HSC differentiation has been described,
(9,10) it is believed that
the endosteal nicheis themost important in terms ofoverallHSC
reserve and proliferation.
(11–13)
OBs have been shown to support HSC differentiation in
vitro
(14–16) and to play an integral role in this process in the
endosteal niche.
(11,17–25) OBs secrete several hematopoietic
cytokines, including G-CSF, IL-1, and IL-6,
(26–28) as well as
osteopontin, an inhibitor of HSC differentiation.
(29,30) Other
endocrine mediators acting on OBs have been shown to impact
differentiation and proliferation of HSCs as well. Parathyroid
hormone stimulates expansion of HSC number locally in the
niche and peripherally in the vasculature.
(31–33) Insulin-like
growth factor (IGF) has been implicated in the regulation of HSC
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1111survival and expansion.
(31) It has been suggested that thrombo-
poietin
(34) and signaling molecules from adipocytes
(35) in yellow
marrow also influence HSC differentiation in the niche.
A key factor in preserving the stem cell pool throughout life is
themaintenanceofthevastmajorityofHSCsatanygiventimein
the quiescent phase of cell cycle.
(36,37) OBs are critical mediators
of this quiescence through intercellular signaling pathways,
(13)
leading to overall increased survival of HSCs.
(38,39) Indeed, it has
been suggested that finding quiescent HSCs in long bones is an
effective means of physically identifying the endosteal niches
themselves.
(40) Clearly, with such complex regulatory interac-
tions both systemically and within the niche, a thorough
understandingofthecompleteroleoftheOBintheregulationof
HSC survival and differentiation would be beneficial for potential
clinical applications involving ex vivo manipulation of HSCs.
Most investigations using co-cultures of OBs with hemato-
poietic progenitor cells (HPCs) end up utilizing OBs and OB
precursors in various stages of maturation and differentiation.
Indeed, as Kiel and Morrison have stated,
(10) most investigators
call endosteal lining cells OBs, although in fact these cells are
heterogeneous and include OB lineage cells at many stages of
maturation, as well as other cells, including osteoclasts. Because
OB lineage cells (which for convenience will be called OBs from
here on) express different cell surface markers and depend on
many intracellular activities as they differentiate and age,
(41,42) it
stands to reason that different subpopulations of OBs may
behave differently with respect to regulation of HSC survival and
differentiation in the niche as they age.
(42) Zhu posited that a
unique subpopulation of OBs may be primarily responsible for
HSC support in niches.
(43) We sought to discern in this study any
appreciable difference in primitive hematopoietic cell expansion
and function when a purified population of stem/progenitor
cells, defined as Lin-Sca1þc-kitþ (LSK) were co-cultured with
OBs and OB precursors in various stages of maturation and
differentiation. Using the knowledge gained from these ex-
periments, we sought to enhance the primary function of HSCs,
namely their bone-marrow-reconstituting potential, by deter-
mining that early-stage or immature OB lineage cells better
promotehematopoieticactivitythandomorematureOBlineage
cells.
Materials and Methods
Animals
C57BL/6 mice (2-day pups) and B6.SJL-PtgcqPep3b/BoyJ (BoyJ)
mice (6 to 8 weeks old) were originally obtained from Jackson
Laboratories (Bar Harbor, ME, USA). Both C57BL/6 mice and BoyJ
mice were subsequently bred, housed, and used to generate F1
progeny at Indiana University. All procedures were approved by
the Laboratory Animal Research Facility of the Indiana University
School of Medicine and followed NIH guidelines.
Preparation and culture of calvarial OB
Neonatal murine calvarial cells were prepared following a
modification of published basic methods.
(44,45) Briefly, calvariae
from C57BL/6 mice less than 48hours old were dissected out,
pretreated with EDTA in PBS for 30minutes, then subjected to
sequential collagenase digestions (200U/mL). Fractions 3 to 5
(digestions 20–35minutes, 35–50minutes, and 50–65minutes)
were collected and used as OBs. These cells are>95% OBs or OB
precursors as previously shown.
(44,46,47) Freshly prepared OBs (0
culture duration) or OBs that were cultured for 1, 2, or 3 weeks
were used for all studies.
OBs cultured for 1, 2, or 3 weeks were cultured in a-MEM
supplemented with 10% FBS and with ascorbic acid (50mg/mL
added on day 0 and at all feedings) and b-glycerophosphate
(5mM added starting on day 7 and all subsequent feedings). It
should be noted that these culture duration studies were set up
in two different waysto control forexperimental variation. In half
of the studies the same starting OB population was used for
fresh, 1-, 2-, and 3-week cultures, and LSK cells were generated
eachweekfromdifferentmice.Intheotherhalfofthestudiesthe
same LSK population was used for all cultures, but the OBs were
generated weekly for 4 weeks.
LSK preparation and cell sorting
Low-density bone marrow cellswere preparedfrom flushed long
bones of BoyJ (CD45.1) mice. Cells were washed once with stain
wash (PBS, 1% bovine calf serum, and 1% penicillin-streptomy-
cin, Pen/Strep) then stained as indicated below for 15minutes
on ice. Briefly, cells were stained with phycoerythrin (PE)–
conjugated lineage markers, including monoclonal antibodies
(Ab) for CD3, CD4, CD45R, Ter119, and Gr1; allophycocyanin
(APC)–conjugated cKit (CD117); and fluorescein isothiocyanate
(FITC)–conjugated Sca1 (BD Biosciences, Rockville, MD, USA). Lin-
Sca1þcKitþ (LSK) cells were sorted on a BDIS FACS Aria (BD
Biosciences).
Co-culture of OB and LSK cells
Freshly prepared OBs or cultured OBs from C57Bl/6 mice
(CD45.2) were plated at 40,000 cells per well in a 12-well plate.
FreshlysortedLSKcells(1000/well)fromBoyJmice(CD45.1)were
added 24hours later. Cultures were supplemented with murine
SCF and IL3 (10ng/mL), IGF1 and TPO (20ng/mL), IL6 and Flt3
(25ng/mL) and osteopontin (50ng/mL); in some experiments
cytokines were not added to assess whether OBs were using or
binding cytokines. Cultures were maintained for 1 week in
medium consisting of a 1:1 mix of Iscove’s modified Dulbecco’s
medium (IMDM) and a-MEM supplemented with 10% FBS, 1%
Pen/Strep, and 1% L-glutamine. Cells were harvested on day 7
and counted. LSK fold increase was calculated by phenotypic
analysis relative to d0 count of 1000. In each experiment, LSK
cells were also seeded in wells containing no OBs as a control.
LSK phenotyping
The entire cell content of each well was harvested and stained
with all of the above antibody combinations except CD117. In
addition, cells were also stained with pacific blue (PB)-
conjugated CD45.1 and phycoerythrin-Cy7 (PE-Cy7)–conjugated
CD45.2. CD45.1þ cells were gated and analyzed for the presence
of Lin-Sca1þ cells. Data were collected on an LSRII flow
cytometer (BDIS) and the percentage of Lin-Sca1þ cells
determined.
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Cultured cells or freshly sorted cells were plated in duplicate in
3-cmpetridishescontaining1mLmethylcellulosewithcytokines
(MethoCult GF M3434, Stem Cell Technologies, Vancouver, BC,
Canada) according to the directions of the manufacturer. Either
500 freshly isolated LSK cells or a predetermined number of
cultured cells (chosen to yield approximately 100 colonies per
3-cm dish) were assayed in each run. Cultures were maintained
at 378C in humidified incubator at 5% CO2 and colonies were
counted on an inverted microscope after 7 days. Colony types
were not enumerated separately and thus a total number of
clonogenic cells was reported.
Cell cycle analysis
Fortheanalysisofcellcyclestatus,co-culturedLSKprogenywere
collected by repeated gentle washing of the cultures to collect
LSK progeny and leave adherent OBs in the plate. Collected cells
were centrifuged and stained with equal volumes of staining
buffer (0.1mg/mL PIþ0.6% Nonidet P40 in PBS) and 2mg/mL
RNase as described previously.
(48) Cells were triturated and
incubated on ice for 30minutes. Data were collected on an LSRII
flow cytometer (BDIS) and the percentages of cells in G0/G1, S,
and G2þM phases were determined by ModFit cell cycle
analysis software (Verity Software House, Topsham, ME, USA).
Cell cycle status of fresh and cultured OB was determined from
separate cultures that were not seeded with LSK cells.
Apoptosis analysis
To analyze apoptosis in cultured LSK cells, co-cultured LSK
progenywerecollected asdescribedaboveforcellcycleanalysis.
Collected cells were then washed once in Dulbecco’s modified
eagle medium (DMEM) followed by the addition of annexin V
conjugated with allophycocyanin (APC). Cells were incubated on
ice for 15minutes, then washed and resuspended in DMEM
followed by the addition of 10mL of 10ng/mL propidium iodide
(PI). Cells were incubated at room temperature for an additional
10minutes and data were collected on an LSRII flow cytometer
(BDIS). The percentage of cells that were positive for annexin V
and negative for PI was determined. Apoptosis of fresh and
cultured OB was also determined, as above, from separate
cultures that were not seeded with LSK cells.
Quantitative real-time (RT) PCR
Total RNA was isolated using RNAeasy kit (Qiagen, Valencia, CA,
USA). DNAse (Qiagen)–treated RNA was used to generate cDNAs
by reverse transcription according to the manufacturer’s
instructions (SuperScript II kit; Invitrogen, Carlsbad, CA, USA).
PCR reactions were performed in an MX3000 detection system
using SYBR green PCR reagents following the manufacturer’s
instructions (Stratagene, La Jolla, CA, USA). For each gene
analyzed (see Table 1 for primer sequences), a calibration curve
was performed and all the oligonucleotides were tested to
ensure specificity and sensitivity. For each sample, arbitrary units
obtained using the standard curve and the expression of GAPDH
was used to normalize the amount of the investigated transcript.
Quantitative analysis of calcium deposition
Calcium deposition was assessed by eluting alizarin red S from
cell monolayers as previously described.
(49) Briefly, monolayers
were washed 2  with PBS, subsequently fixed in ice-cold 70%
(v/v) ethanol for1 hour,then washed 2 with water. Monolayers
were stained with 40mM alizarin red S (pH 4.2) for 10minutes
(room temperature, shaking), unbound dye was removed by
washing with water (5 ) and with PBS (1  for 15minutes,
room temperature, shaking). Bound alizarin red was eluted by
incubating monolayers with 1% (v/v) cetylpyridinium chloride
in 10mM sodium phosphate (pH 7.0) for 15minutes (room
temperature, shaking). Absorbance from aliquots was measured
at 562nm (GENios Plus, Tecan, San Jose, CA, USA), and alizarin
red concentrations were calculated from measured standards
(Ca/mol of dye in solution).
Transplantation studies
In order to examine the long-term repopulating potential of in
vitro cultured LSK cells, 2000 LSK cells per well in a 12-well plate
were co-cultured for 5 days in the presence of freshly isolated or
3-week OBs. On day 5, the entire contents of each well were
harvested and injected via the tail vein into a lethally irradiated
(1050 cGy split dose, 3–4hours apart) C57BL/6 X BoyJ F1
recipient (CD45.2/CD45.1) along with 100,000 competitor low-
densitybonemarrowcellsfromBoyJmice(CD45.1).Controlmice
received 2000 LSK cells (freshly isolated) and 100,000 competitor
cells. To determine whether transplantation of OBs along with
LSKcellsfacilitatesengraftment,additionalcontrolmicereceived
2000 LSK cells (freshly isolated) and 100,000 competitor cells as
well as OBs. Specifically, 40,000 freshly isolated OBs were plated
for5days(asdetailedforco-culturesoffreshOBsþLSKcells),the
well was trypsinized, and OB cells were counted and injected
with freshly isolated LSK and competitor cells into mice.
Transplanted mice received doxycyclin-treated commercial feed
pellets for 2 weeks prior to and 3 weeks after transplantation. At
monthly intervals, for 4 months, chimerism in blood was
assessed as CD45.2/(CD45.2þCD45.1) 100. This calculation
was therefore independent of any residual host-derived HSC
activity. The mice were euthanized at 4 months, and bones were
collectedandmarrowflushedoutofthefemurs.Themarrowwas
then stained as described above with CD45.1 and CD45.2
antibodies, and chimerism was also determined as described
above.
Statistical analyses
Unless otherwise indicated, data are presented as the mean
 the standard error associated with the mean. Student’s t tests
were performed when only two groups were compared. One-
way factorial analyses of variances were used to make multiple
group comparisons. Pair-wise Bonferroni comparisons were
made to explore individual group differences while controlling
for the elevated family-wise error associated with performing
multiple comparisons. Linear regressions using analysis of
variance model were performed to compare continuous data
groups. All analyses were performed with Statistical Package for
SocialSciences(SPSS16;Norusis/SPSS,Chicago,IL,USA)software
and were 2-tailed with a level of significance set at 0.05.
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OBs enhance HPC proliferation, CFU expansion,
maintenance of primitive phenotype, and plating
efficiency
It is well understood that OBs play an important role in the HSC
niche. Our goal in this study was to determine whether OB
maturation altered hematopoietic potential of primitive pro-
genitor cells. However, we had to first show that in our model
system, OBs enhance in vitro hematopoiesis, which is usually
assessed through increased numbers of clonogenic cells and
cells that maintain the original phenotype of primitive
progenitors, in this case the LSK phenotype. As shown in
Fig. 1, compared with LSK cells cultured alone, co-culture with
OBs promoted all HPC properties tested. As illustrated in Fig. 1,
LSK cells cultured alone (n¼6–8) versus LSK cells co-cultured
with OBs (n¼7–9) for 7 days resulted in the following:
hematopoietic cell proliferation (2.1 0.8 10
6 vs. 3.5 1.0 
10
6, p¼.008; Fig. 1A), production of clonogenic cells
(11,400 7500 vs. 32,400 11,200, p<.001; Fig. 1B), percentage
of Lin-Sca1þ cells (14.5 8.7% vs. 29.5 9.5%, p¼.01; Fig. 1C),
and plating efficiency (11.6 7.2 vs. 22.9 4.8, p¼.002; Fig. 1D).
We also established co-cultures in the absence of cytokines
and examined hematopoietic cell proliferation (Fig. 1A). While
hematopoietic cells added to OBs survived for a period of 7 days
in the absence of cytokine supplementation (whereas hemato-
poietic cells cultured without OBs and without cytokines did not
survive, data not shown), the degree of expansion of these cells
during this period was very limited and precluded the pursuit of
characterizing the function of these cells. It should also be noted
that since c-kit expression is lost
(50–52) when cells are exposed to
SCF, we determined the percentage of Lin-Sca1þ cells instead of
Lin-Sca1þc-kitþ cells on day 7. Supplemental Fig. 1A illustrates
this loss of c-kit expression for Lin-Sca1þ cells. The ligand for
c-kit, SCF, is expressed in OBs at the same levels regardless of
Table 1. Primer Sequences for Real-Time PRC Reactions
Runx2 forward primer 5’ CGACAGTCCCAACTTCCTGT
Runx2 reverse primer 5’ CGGTAACCACAGTCCCATCT
Alkaline phosphatase forward primer 5’ GCTGATCATTCCCACGTTTT
Alkaline phosphatase reverse primer 5’ CTGGGCCTGGTAGTTGTTGT
Osteocalcin forward primer 5’ AAGCAGGAGGGCAATAAGGT
Osteocalcin reverse primer 5’ TTTGTAGGCGGTCTTCAAGC
Osteopontin forward primer 5’ ACTCCAATCGTCCCTACAGTCG
Osteopontin reverse primer 5’ TGAGGTCCTCATCTGTGGCAT
Type I collagen forward primer 5’ CAGGGAAGCCTCTTTCTCCT
Type I collagen reverse primer 5’ ACGTCCTGGTGAAGTTGGTC
Jagged 1 forward primer 5’ TCCAGGTCTTACCACCGAAC
Jagged 1 reverse primer 5’ GGACGCCTCTGAACTCTGAC
Jagged 2 forward primer 5’ GAGGTCAAGGTGGAAACAGT
Jagged 2 reverse primer 5’ TGTCCACCATACGCAGATAA
Stem cell factor forward primer 5’ CCTTAGGAATGACAGCAGTAG
Stem cell factor reverse primer 5’ AGCCAATTACAAGCGAAATGAG
GAPDH forward primer 5’ CGTGGGGCTGCCCAGAACAT
GAPDH reverse primer 5’ TCTCCAGGCGGCACGTCAGA
Fig. 1. LSK cells were cultured alone or in the presence of freshly
prepared OBs for 7 days and the following parameters were measured:
(A)totalnumberofhematopoieticcellsinculture;(B)totalnumberofCFU
produced in culture; (C) percentage of cells expressing Lin-Sca1þ cell
surface markers; and (D) plating efficiency of clonogenic cells (number of
CFUs/number of cells assayed 100). Data are presented as the mean
 the standard deviation. Co-culture of LSK cells with OBs significantly
increased all hematopoietic parameters analyzed relative to LSK cells
cultured alone.
 Indicates statistically significant differences (p<.05)
compared to LSK cells alone for identical HPC measurements.
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SupplementalFig.1B).Althoughtheexperiments presentedhere
use neonatal calvarial OBs, we previously demonstrated that OBs
derived from both long bones (in a manner similar to that
described by Balduino et al
(53)) and calvariae of neonatal and
young adult mice resulted in enhancement of the same
hematopoietic properties studied here.
(54)
Effects of OB culture duration on HPC proliferation, CFU
expansion, maintenance of primitive phenotype, plating
efficiency, cell cycle status, and apoptosis
To determine the effects of OB culture duration on HPC
properties, we co-cultured LSK cells for 1 week with freshly
prepared OBs (n¼7–9) or OBs cultured for various durations (1
week, 2 weeks, or 3 weeks, n¼2 for all groups), in complete
medium, prior to co-culture with LSK cells. Bonferroni post hoc
corrections were performed because multiple comparisons were
made. As shown in Fig. 2, freshly prepared OBs were significantly
better at enhancing all HPC properties than OBs cultured for any
duration prior to co-culture with LSK cells , with the exception of
1-week OB plating efficiency.
Total hematopoietic cell number was significantly higher in
cultures containing fresh OBs (3.5 0.3 10
6) compared with
OBs cultured for 1 week (1.2 0.4 10
6, p¼.05), 2 weeks
(1.0 0.5 10
6, p¼.03), or 3 weeks (0.8 0.3 10
6, p¼.02)
prior to LSK seeding (Fig. 2A). Total CFU number was also
significantly elevated in fresh OB co-cultures (34,300 4000)
compared with OBs cultured for 1 week (9200 1500, p¼.04),
2 weeks (3300 600, p¼.01), or 3 weeks (1800 800, p¼.007)
prior to co-culturing with LSK cells (Fig. 2B). Further, the
percentage of Lin-Sca1þ cells was also significantly higher in
fresh OB co-cultures (29.5 3.6%) compared with OBs cultured
for 1 week (5.3 0.9, p¼.02), 2 weeks (0.9 0.2, p¼.008), or
3 weeks (1.0 0.2, p¼.008) prior to LSK seeding (Fig. 2C). Finally,
the plating efficiency was significantly increased in fresh OB co-
cultures (22.9 1.6%) relative to OBs cultured for 2 weeks
(9.5 3.5%, p¼.02) or 3 weeks (5.5 0.5, p¼.003) but not
1 week (17.3 3.3%, p¼.86) prior to LSK seeding (Fig. 2D). It
should be noted that, as shown in Fig. 1, when LSK cells were
cultured without OBs, hematopoietic parameters tested were
significantly lower than those observed with fresh OBs; however,
no significant differences were detected when comparing LSK
cells cultured alone to LSK cells co-cultured with 1-week OBs.
Next, we conducted additional studies to examine the
apoptotic and cell cycle status of hematopoietic cells following
co-culture with OBs. Because the hematopoietic cell proliferation
was markedly and similarly reduced in 1-, 2-, and 3-week OB
Fig. 2. LSKcellswereco-culturedwithfreshlypreparedOBsorwithOBsculturedincompletemediumfor1,2,or3weekspriortoco-culturewithLSKcells.
After 7 days of co-culture, hematopoietic cells were assayed as follows: (A) total number of hematopoietic cells in culture; (B) total number of CFUs
produced in culture; (C) percentage of cells expressing Lin-Sca1þ cell surface markers; and (D) plating efficiency of clonogenic cells (number of CFUs/
number of cells assayed 100). Results are reported as box plots representing the range of data points, with the line representing the average. Error bars
represent the standard deviations associated with the mean. Data points more than 2 standard deviations from the mean are identified on the plot but
were used in statistical determinations. For all hematopoietic parameters analyzed, results from freshly prepared OB cultures were superior to those from
OB cultures previously cultured for 1, 2, or 3 weeks prior to co-culture.
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and 1-week OB cultures only. The cell cycle data for
hematopoietic cells cultured with fresh OBs, 1-week OBs, or
cultured alone (plastic) is shown in Fig. 3 (n¼3/group). No
significant differences were detected in the percentage of
cycling cells (S-G2/M phases). Also seen in Fig. 3 is the cell cycle
status of the fresh and 1-week OBs that were cultured alone. As
would be expected, freshly seeded OB cultures contained
significantly more cells in the active phases of cell cycle than 1-
week OB cultures, which generally obtain confluence by day 5.
With regard to apoptosis, in all of the cultures tested (same as
those tested for cell cycle status) less than 1% of cells
(hematopoietic or OB) were undergoing apoptosis defined
as annexin Vþ PI- cells (data not shown). Thus, loss of
hematopoietic function observed in cultures where OBs have
been seeded for 1 or more weeks does not appear to be due to
alterations in cell cycle status or apoptosis.
Effects of OB cell number on HPC proliferation, CFU
expansion, maintenance of primitive phenotype, and
plating efficiency
Because all OBs were seeded at the same original concentration,
cultures containing freshly prepared OBs had fewer total OBs
than did the other cultures, both at initiation and possibly
throughout the co-culture period. Therefore, it is formally
possible that OB cell number alonecould explain the data shown
in Fig. 2, due to a crowding effect. Here we show data from
separate studies to address this issue.
In parallel cultures, 1-week (n¼4), 2-week (n¼4–5), and 3-
week (n¼6) OB cultures were trypsinized, and these cells were
seeded again at the same concentration as freshly prepared OBs
(n¼7–9). All groups were co-cultured with LSK cells for 1 week
and LSK properties were determined. Proliferation and CFU data
from these studies showed the same trend described in Fig. 2
(data not shown): freshly prepared OBs were superior to
trypsinized OBs cultured for 1, 2, or 3 weeks for all hematopoietic
parameters tested. With respect to the percentage of Lin-Sca1þ
cells and the plating efficiency, the trends are the same as those
seen in Fig. 2. However, significant differences were detected
only between freshly prepared OBs and OBs trypsinized after
3 weeks for plating efficiency (data not shown).
LSK cells co-cultured with fresh OBs have a higher
repopulating potential than LSK cells co-cultured with
3-week OBs
We previously demonstrated that LSK cells harvested after
10 days of co-culture with fresh OBs were capable of
repopulating the marrow of lethally irradiated recipients at
levels comparable to those obtained with freshly isolated LSK
cells (when expansion-equivalent numbers of cells are used) and
of sustaining high and comparable levels of chimerism in
secondary recipients.
(54) Here, we performed similar studies
where LSK cells were co-cultured with fresh or 3-week OBs for
5daysandthecontentsofeachwellwereharvestedandinjected
along with 100,000 competitor cells into lethally irradiated
recipient mice. As a control we transplanted freshly isolated LSK
cells with 100,000 competitor cells. For an additional control we
transplanted freshly isolated LSK cells with competitor cells, as
well as the progeny of 40,000 freshly isolated OBs maintained in
culture for 5 days. This latter control was used to show whether
the transplantation of OBs along with LSK cells facilitates
engraftment. As illustrated in Fig. 4, transplantation of OBs along
with LSK cells did not affect the percentage engraftment as
measured in monthly peripheral blood analyses and in 4-month
bone marrow cell analyses (group 1 vs. group 2). With respect to
the long-term repopulating potential of LSK cells co-cultured
with fresh versus 3-week OBs, data in Fig. 4 show the significant
reduction in chimerism when LSK cells were co-cultured with 3-
week OB compared with fresh OBs (p<.000002 for all monthly
blood analyses and bone marrow analyses). Further, our data
also suggest that co-culture with OBs enhances the expansion of
a group of short-term repopulating cells, as evidenced by the
significantly higher level of chimerism at 1 month post-
transplantation in the group of mice receiving LSK cells co-
cultured with fresh OBs (p¼.009, group 1 vs. group 3). This
observation was previously noted in similar experiments
reported by our group.
(54)
Characterization of gene expression and calcium
deposition in OB cultures
Freshly isolated OBs are likely composed of cells of different
developmental stages, and it is generally thought that with
longer culture duration and with supplementation of ascorbic
acid and b-glycerophosphate, OBs become more differentiated.
To examine the effects of culture conditions on OB maturation,
we examined expression of genes for Runx2, alkaline phospha-
tase, type I collagen, osteopontin, and osteocalcin. We also
examined calcium deposition as a marker for mineralization. All
parametersweremeasuredinparallelcultureswhenLSKseeding
would occur.
Fig. 3. LSK cells were cultured alone or were co-cultured with freshly
prepared OBs or with OBs cultured for 1 week. After 7 days of co-culture,
hematopoietic cells were removed by washing and cell cycle status was
assessed by staining with propidium iodide. No differences in the
percentage of hematopoietic cells in the S/G2þM phases of cell cycle
were observed. In parallel studies, fresh and 1-week OBs were cultured
alone and OB cell cycle status determined as above. As would be
expected, a higher percentage of fresh OBs were in the active phases
of cell cycle than those cultured for 1 week. In data not shown, we also
analyzed both hematopoietic and OB cells for the expression of
annexin V. In all cases, less than 1% of the cells were annexin V positive,
suggesting that apoptosis was not detected.
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OB maturation and is reduced as OB differentiation progresses.
As detailed in Fig. 5A, Runx2 expression was highest in fresh OB
cultures. Alkaline phosphatase is the major enzyme expressed
by OB. Figure 5B illustrates that alkaline phosphatase expres-
sion increased up to 2 weeks of culture duration then
maintained this high level at 3 weeks. Type I collagen is the
main collagen produced by OBs. Osteopontin and osteocalcin
are two of the main noncollagenous bone matrix proteins
produced by OBs. Figure 5C-E shows that as OB culture duration
increases, type I collagen, osteopontin, and osteocalcin expres-
sion all increase, which is consistent with increasing OB
maturation. It is important to note the striking increase in
osteocalcin expression. It is well known that osteocalcin
expression turns on late in OB differentiation, which is consistent
with maturation increasing relative to increasing OB culture
duration in our studies.
Finally, we confirmed OB function by measuring calcium
deposition. It is well known that addition of ascorbic acid and b-
glycerophosphate to OB cultures enhances OB differentiation
and mineralization.
(55) Therefore, it is not surprising that calcium
deposition was increased when OB culture duration increased
(Fig. 5F).
Next, we performed a linear regression using analysis of
variance model (ANOVA) to determine whether significant
associations were found between independent and dependent
variables. Pearson’s correlation coefficient was used to deter-
mine R
2 values. First, we wanted to determine whether
significant associations were found between OB culture duration
and OB gene expression/calcium deposition. These analyses
showed that OB culture duration is significantly associated with
expression of alkaline phosphatase (p¼.007, R
2¼.733), type I
collagen (p¼.04, R
2¼0.549), osteopontin (p¼.05, R
2¼0.494),
osteocalcin (p¼.002, R
2¼0.808), and calcium deposition
(p<.001, R
2¼0.545). Statistical significance was not achieved
for associations between OB culture duration and Runx2
expression.
Second, we wanted to determine whether significant
associations existed between HPC properties and OB gene
expression/calcium deposition. The data show that Runx2 is
significantly associated with hematopoietic cell number (p¼.03,
R
2¼0.828) and the percentage of Lin-Sca1þ cells sustained for
7 days in co-cultures of OB and LSK cells (p¼.04, R
2¼0.789).
While the association did not reach significance between Runx2
and number of clonogenic cells (p¼.06, R
2¼0.734) it was by a
small margin, but significance was reached between Runx2
expression and chimerism in repopulation studies (p¼.02,
R
2¼0.916). The data also show that chimerism in repopulation
studies is significantly and inversely associated with OB
expression of alkaline phosphatase (p¼.007, R
2¼0.974), type
Icollagen(p¼.009,R
2¼0.964),osteopontin(p¼.03,R
2¼0.897),
and osteocalcin (p¼.003, R
2¼0.988). Further, these analyses
showed that calcium deposition is inversely associated with
hematopoietic cell number (p¼.002, R
2¼0.713), number of
clonogenic cells (p¼.01, R
2¼0.561), percentage of Lin-Sca1þ
cells sustained for 7 days in co-cultures of OB and LSK cells
(p¼.007, R
2¼0.664), and chimerism in repopulation studies
(p<.001, R
2¼0.962). While the association did not reach
significance for plating efficiency, it was by a small margin
(p¼.08, R
2¼0.342).
In all of the above analyses the effects of OB properties on
hematopoietic enhancing activity was examined. That said, it is
possible that co-culture of hematopoietic cells with OBs may
alter OB maturation, which in turn can impact hematopoietic
cells. We therefore cultured OBs in the presence or absence of
LSK cells for 1 week, removed LSK cells by gentle washing as
detailed above, and isolated mRNA from OBs for real-time PCR
analysis. For these studies we examined the same gene products
examined above (Runx2, alkaline phosphatase, type I collagen,
osteopontin, osteocalcin), as well as Jagged1 and Jagged2.
Jagged1 and Jagged2 are both Notch ligands that are highly
expressed on OBs. Notch signaling has been shown by us
(54) and
others
(56) as being important in OB-induced hematopoietic-
enhancing activity. There were no significant differences
detected for any of these genes in OBs cultured alone or in
the presence of LSK cells (data not shown). Similarly, in previous
studies, we did not detect differences in OB morphology or cell
number when comparing OBs cultured alone to OBs co-cultured
with LSK cells.
(57) Taken together, these data appear to suggest
that OB lineage cells responsible for the hematopoiesis-
enhancing activity are present in the culture de novo.
Fig. 4. Repopulating potential of freshly isolated LSK cells in the pre-
senceandabsenceoffresh OBsandin vitroexpanded LSKcellsfor5 days
in co-cultures of fresh OBs and 3-week OB cultures. Data are from
one experiment and 5 mice per group were analyzed. Chimerism in
the peripheral blood at 1 and 4 months post-transplantation and in the
marrow at 4 months shows significantly better engraftment from LSK
cells expanded in fresh OB cultures than with LSK cells expanded in 3-
week OB cultures. Data are presented as the mean the standard
deviation.
 Indicates, statistically significant differences (p<.05) com-
paredtofreshLSK(group1).
YIndicatesstatisticallysignificantdifferences
(p<.05) compared with LSK co-cultured with fresh OBs (group 3).
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Our findings illustrate that OBs sustain HPC survival and
proliferation and that this support is dependent on the stage
of maturation and differentiation of the OBs. Using multiple in
vitro functional assays and phenotypic assessment of cultured
hematopoietic cells, we demonstrated that fresh OBs supported
significantly higher HPC expansion compared with what was
observed with LSK cells cultured alone. This OB support of
hematopoiesis declined when OBs were cultured for increasing
durations.ThatculturedOBsmaturedanddifferentiatedduringa
period of 3 weeks was shown by both functional and molecular
determinations. Importantly, in vivo transplantation studies
corroborated our in vitro results with respect to the relationship
between HPC support and stage of OB maturation. Furthermore,
our in vitro data are consistent with, and relevant to, aging. It is
well understood that with age, bone mass is lost, OB number is
reduced, and HSC/HPC function also declines.
(58–62) Our
previously published histomorphometric mouse bone data also
support the reduction in bone volume and OB number with
age.
(63) Indeed, we reported in control mice an approximately
2.5-fold reduction in bone volume and a greater than 10-fold
reduction in OB number in 9-month-old mice compared with
thatin6-week-oldmice.Inourstudiespresentedhere,extending
OB culture duration allows for OB maturation; therefore, 3-week
OB cultures contain fewer early-stage or immature OB lineage
Fig. 5. Characterization of mRNA expression and calcium deposition in OB cultures (7 days following experiment initiation) from freshly prepared OBs or
OBs cultured for 1, 2, or 3 weeks prior to experiment initiation. It should be noted that for all (A–E) gene expression data and ( F) calcium deposition data,
levels were normalized to levels measured in cultures of fresh OBs. Results are reported as box plots representing the range of data points, with the line
representing the average. Error bars represent the standard deviations associated with the mean (all error bars are graphed and in some cases the error
bars are within the box plots). There were no data points more than 2 standard deviations from the mean. (A) Runx2 expression was highest in freshly
isolatedOBsanddeclinedwithcultureduration.(B)Alkalinephosphataseexpressionincreasedwithcultureduration,peakingatweek2,andthislevelwas
maintained in week 3 cultures. As expected, expression of (C) type I collagen, (D) osteopontin, and (E) osteocalcin, as well as ( F) calcium deposition,
increased as OB culture duration increased.
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culturesmimictheinvivolossofearlystageOBlineagecellsseen
in aging. Furthermore, in both our in vitro studies and in aging,
HSC/HPC function is reduced.
With respect to our in vitro studies, fresh OBs promoted a
significantly higher level of HPC expansion (total cell number
produced in culture), CFU production, and maintenance of Lin-
Sca1þ cells in culture than did OBs cultured for 1, 2, or 3 weeks.
Given that c-kit expression (CD117) is quickly downregulated
through the internalization of the receptor in cultures sup-
plemented with exogenous SCF,
(50–52) we did not use CD117 to
track the phenotypic makeup of cultured cells (Supplemental
Fig. 1). Still, evaluation of Lin-Sca1þ cells is a valid approach for
measuringthe maintenance ofprimitiveHPCs inculture. Ofnote,
when LSK cells were co-cultured with OBs alone (no additional
cytokines added) a similar trend in expansion of hematopoietic
cell number was observed, albeit to a much lesser extent, which
limited our ability to conduct further analyses.
Interestingly, with respect to cytokine-supplemented cultures,
a slightly different picture was seen with plating efficiency.
For this parameter, no difference was detected between freshly
prepared OBs and those cultured for 1 week. However,
significant differences were detected between freshly prepared
OBs and those cultured for either 2 or 3 weeks prior to LSK
seeding. The lack of difference in plating efficiency observed
between freshly prepared OBs and those cultured for 1 week is
likely owing to the fact that plating efficiency may not change as
dramatically and quickly as the other parameters reported. No
differences in cell cycle status or apoptosis were observed in
hematopoietic cells co-cultured with fresh OBs or with 1-week
OBs. Thus, the loss of hematopoietic function observed in
cultures where OBs have been seeded for 1 or more weeks does
not appear to be due to alterations in cell cycle status or
apoptosis, but rather due to intrinsic differences in fresh versus
cultured OBs.
In our model system, a confluent monolayer of freshly
prepared OBs is observed within 2 to 3 days. Only in the fresh OB
culture are LSK cells present for few days in a nonconfluent
environment, so although cell number should be theoretically
similar in all cultures by day 7 (because of contact inhibition), it is
formally possible that the higher cell number in the 1-, 2-, and 3-
week cultures immediately after seeding with LSK cells could
haveaccountedforthedeclineinLSKpropertiesbecauseofacell
‘‘crowding phenomenon’’ and possible limited access to
nutrients. We addressed this possibility by reseeding the more
mature OBs grown for 1, 2, and 3 weeks at identical starting
concentrations and assessing HPC properties. These studies
recapitulated all of the data obtained in the main arm of this
study, including the plating efficiency results showing that our
findings were not an artifact of crowding or nutrient consump-
tion, but were instead related directly to OB culture duration and
presumably the stage/maturation of the OBs in culture.
Wethensoughttoconfirmourinvitrofindingsusingthe‘‘gold
standard’’ in vivo reconstitution studies. Given that we have
recently shown that LSK cells maintained in co-cultures with
fresh OBs for 10 days maintain their in vivo repopulating
potential,
(54) we examined, in a similar system, the ability of LSK
cells co-cultured with fresh or 3-week OBs to engraft and sustain
in vivo hematopoiesis. Since differences in the in vitro
hematopoietic functions were highest between fresh and 3-
weekOBs,wechosethosetwoco-culturesforinvivostudies.Our
in vivo data corroborated in vitro results in that LSK cells
maintained in culture with fresh OBs for 5 days supported a
significantly higher level of chimerism than their counterparts
maintained with 3-week OBs (Fig. 4). Importantly, in conducting
these studies, we included control groups to determine whether
engraftment was facilitated by the OBs contained within the
harvested wells. In our system, OBs themselves were not
responsible for enhancing engraftment; rather, in vitro expan-
sion of LSK cells on the OBs was necessary for the enhanced
engraftment. These in vivo data are significant because they
provide a strong confirmation of our claim that fresh, less mature
OBs support the hematopoietic function of progenitor cells
better than more mature or cultured OBs.
That OBs cultured for 2 or 3 weeks in our system represent
differentiated or mature osteoblastic lineage cells as previously
speculated
(64) was confirmed by examining well-established
markers. As would be expected from a maturation-associated
pattern of expression or loss of expression of OB-specific
markers, we observed a time-dependent loss of Runx2, a
transcription factor required for OB differentiation; an increase in
the expression levels of type I collagen, osteopontin, osteocalcin;
and an increase in the main osteoblastic enzyme, alkaline
phosphatase. Consistent with these patterns, cultured OBs
deposited greater amounts of calcium in a time-dependent
manner, as previously shown.
(41) Calcium has been suggested to
behighly influentialinpromotingthe survivalanddifferentiation
of HSCs in the niche.
(65) We believe that the inverse relationship
detailedheredoesnotstandincontrasttothisprinciple,because
calcium deposition in our studies was used as a marker for OB
mineralization
(66,67) and does not reflect the amount of
bioavailable calcium. Coupled with in vitro and in vivo functional
data, these results show that early-stage OBs are superior in
enhancing or maintaining hematopoietic progenitor and stem
function, including the marrow-repopulating potential of these
cells.
At face value, our data do not show whether the
hematopoietic-supportive OB lineage cell is in the culture de
novo or whether culture with LSK cells alters OB differentiation
such that this alteration is responsible for the hematopoiesis-
enhancing activity. To examine this possibility, we cultured OBs
alone and in the presence of LSK cells for 1 week and analyzed
OB mRNA expression of Runx2, alkaline phosphatase, type I
collagen, osteopontin, osteocalcin, Jagged1, and Jagged2. No
differences were observed, suggesting that LSK cells themselves
do not appear to alter OB differentiation. These data suggest,
therefore, that the hematopoietic-supportive OB lineage cell is
most likely present de novo and not modified with LSK culture.
Overall, these data suggest a dynamic relationship between
hematopoiesis and the state of turnover of OBs in the
hematopoietic niche. Based on our results, increasing the
number of early stage OBs in the hematopoietic niche through
pharmacologic or chemical interventions may be an effective
technique for optimizing the therapeutic benefit of stem cell
transplantation in cancer patients, as previously suggested.
(68–70)
Furthermore, our results begin to explain the possible relation-
OSTEOBLAST MATURATION IMPACTS HEMATOPOIETIC STEM CELLS Journal of Bone and Mineral Research 1119ship between aging and hematopoiesis as a result of OB activity.
This activity is substantially increased in times of high bone
turnover and remodeling as observed in the pediatric popula-
tion, which is mirrored by increased levels of hematopoiesis. As
bone ages and red marrow diminishes, so, too, do bone turnover
and OB activity diminish. This concept has been suggested
previously
(71)andwouldwarrantfurtherinvestigation.Moreover,
other pathologies in which OB activity is either accelerated or
diminished may also bear a correlation to hematopoietic
abnormalities. In conclusion, while OBs in general are known
to exert a regulatory effect on HSCs in the hematopoietic niche,
our results provide evidence that OBs in earlier stages of
differentiation may be primarily responsible for these activities.
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